Search within Therapeutic Immunology Group Web Site:
Mirrored TIG Web sites:
Therapeutic Immunology Group (TIG)
Welcome to our Home Page
The Therapeutic Immunology Group is undertaking basic research into the mechanisms of immune tolerance and how these can be harnessed, using monoclonal antibodies (mAbs) and other modern biotherapeutics, to develop clinical treatments for human diseases that involve disregulation or inappropriate reactions of the Immune System such as in autoimmunity or transplant rejection.
The Therapeutic Immunology Group is headed by:
Therapeutic Immunology Group,
Sir William Dunn School of Pathology,
South Parks Road,
Oxford, OX1 3RE
Tel: +44 (0) 1865 275500 (Enquiries)
Fax: +44 (0) 1865 275501
We are principally funded by: 1) The Medical Research Council Program Grant: "Therapeutic Immunoregulation" (until December 2013).
2) BetaCellTherapy: part of a European 7th Framework Network for Beta cell therapy in Diabetes.
TIG is made up of the following Labs:
Past members of TIG
"Developing short-term treatments for long-term outcomes"
This Site Last Updated 16th January 2013 by Steve Cobbold